Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.68	20.75	44.58	69.72	66.84	51.21
Short-Term Investments	45.17	54.31	45.6	37.08	66.98	48.65
Cash & Short-Term Investments	47.85	75.06	90.18	106.8	133.82	99.86
Cash Growth	-42.51%	-16.77%	-15.56%	-20.19%	34.00%	39.25%
Other Receivables	-	0.99	1	1.13	-	-
Receivables	-	0.99	1	1.13	-	-
Prepaid Expenses	3.87	1.17	1.2	1.48	1.24	0.99
Other Current Assets	-	0.21	1.36	2.27	2.8	5.21
Total Current Assets	51.72	77.44	93.75	111.67	137.86	106.06
Property, Plant & Equipment	0.77	0.62	0.68	1.43	1.1	1.33
Long-Term Investments	-	0.08	3.58	19.93	50.46	16.76
Goodwill	-	17.63	-	-	-	-
Other Intangible Assets	64.53	63.67	5.9	-	-	-
Other Long-Term Assets	9.51	8.47	-	0.19	0.04	0.22
Total Assets	126.52	167.9	103.91	133.23	189.47	124.37
Accounts Payable	1.62	2.03	0.57	4.91	3.56	3.08
Accrued Expenses	3.8	3.12	1.86	8.39	13.16	5.82
Current Portion of Leases	-	0.06	0.45	0.74	0.24	-
Other Current Liabilities	-	4.36	0.19	0.18	0.04	-
Total Current Liabilities	5.43	9.57	3.07	14.22	17	8.89
Long-Term Debt	14.9	13.43	-	-	-	-
Long-Term Leases	0.45	0.32	-	0.42	0.21	-
Long-Term Deferred Tax Liabilities	5.38	5.3	0.25	-	-	-
Other Long-Term Liabilities	55.43	54.19	-	-	-	-
Total Liabilities	81.59	82.82	3.32	14.64	17.2	8.89
Common Stock	0.04	0.04	0.04	0.03	0.03	0.03
Additional Paid-In Capital	405.48	401.64	389.11	355.23	318.57	185.2
Retained Earnings	-364.01	-319.64	-288.26	-236.6	-146.65	-69.81
Comprehensive Income & Other	3.42	3.05	-0.29	-0.08	0.31	0.06
Total Common Equity	44.93	85.08	100.59	118.59	172.26	115.48
Shareholders' Equity	44.93	85.08	100.59	118.59	172.26	115.48
Total Liabilities & Equity	126.52	167.9	103.91	133.23	189.47	124.37
Total Debt	15.35	13.81	0.45	1.16	0.45	-
Net Cash (Debt)	32.5	61.25	89.73	105.64	133.37	99.86
Net Cash Growth	-60.92%	-31.74%	-15.06%	-20.79%	33.56%	39.25%
Net Cash Per Share	0.76	1.64	2.68	3.55	4.57	5.25
Filing Date Shares Outstanding	42.97	43.22	36.28	30.15	29.55	29.4
Total Common Shares Outstanding	42.97	42.97	36.14	30.07	29.54	26.87
Working Capital	46.29	67.87	90.68	97.45	120.87	97.16
Book Value Per Share	1.05	1.98	2.78	3.94	5.83	4.30
Tangible Book Value	-19.6	3.79	94.69	118.59	172.26	115.48
Tangible Book Value Per Share	-0.46	0.09	2.62	3.94	5.83	4.30
Machinery	-	0.68	0.43	0.61	0.46	0.43
Leasehold Improvements	-	0.04	0.02	0.06	0.02	-

Source: S&P Capital IQ. Standard template. Financial Sources.